microcytic anemia. She was admitted to a local hospital once a month for the preceding four months and received treatment for the distal intestinal obstruction syndrome (DIOS). Colonoscopy and biopsies showed an obstructive carcinoma in the midtransverse colon. A single contrast hypaque enema revealed a 6 cm circumferential narrowing of the transverse colon. A computerized tomographic scan showed thickening of the transverse colon and possible local lymphadenopathy. The carcinoma was surgically resected. Pathology: Within the centre of the resected segment of colon there was an annular 4x6 cm tumour mass with heaped-up margins and central ulceration, causing a focal stricture of the colonic lumen. On cut section the tumour measured 2 cm in maximum thickness. Microscopic sections showed a moderately differentiated adenocarcinoma ( Figure  1 ) that infiltrated the full thickness of the bowel wall into the subserosal fat. Eight of 13 regional lymph nodes were positive for metastatic adenocarcinoma (Figure 2 ). Involvement varied from subcapsular microscopic foci to extensive replacement of the node and involvement of extranodal soft tissue.
She had adjuvant therapy with 5-fluorouracil and levamisole. Seven months later there was no evidence of recurrent carcinoma. Case 2: A 51-year-old woman had a long history of bronchitis, recurrent pneumonia, bronchiectasis and chronic sinusitis. At age eight a bolus of hair was surgically removed from the cecum. She had chronic abdominal pain and constipation attributed to 'nerves', which was treated with laxatives. Testing at age 30 revealed hemoglobin of 3.1 mmol/L) and stools positive for hemoccult. Anemia was attributed to the effects of chronic disease and hemorrhoids.
Several months later (and two months after a right upper lobectomy for bronchiectasis) she developed severe abdominal cramps. A barium enema showed a tumour mass in the transverse colon. At age 31, a carcinoma in the transverse colon was resected. Her paternal grandfather had colonic cancer.
Despite the long history of chronic pulmonary and sinus disorders, CF was not diagnosed until she was 36 years old. Her genotype was later identified as Delta-F 508/unknown. Two of her five brothers were also shown to have CF. She has never required pancreatic enzyme supplements. Pathology: Within the resected segment of the transverse colon there was a fungating markedly constrictive tumour mass measuring about 7 cm in diameter. Microscopic sections showed a relatively well differentiated adenocarcinoma extending into the bowel wall but not infiltrating through it. Sections through seven lymph nodes showed no evidence of metastatic tumour.
In the 20 years since her colonic resection she has had intermittent diarrhea and constipation, with occasional cramps across the lower abdomen. She had three small colonic adenomas demonstrated at colonoscopy in the past two years.
DISCUSSION
The two patients described here were among 187 patients seen in the British Columbia Adult CF Clinic in Vancouver from 1980 to 1995. Both patients were 31 years old when the carcinoma was diagnosed. In this age group, carcinoma of the colon is distinctly rare. In British Columbia, the incidence of colonic carcinoma in females from birth to age 34 was 0.5/100,000 in 1992 (3).
Abdominal pain, including the DIOS (4,5), and iron deficiency (6) are common in patients with CF. The diagnosis of colonic carcinoma in both patients was delayed. In case 1, her symptoms mimicked those of the DIOS, although her abdominal pain was of relatively recent onset. At diagnosis she had metastatic involvement of the regional lymph nodes. In case 2, her severe anemia had been wrongly diagnosed. Despite a long history of chronic pulmonary and sinus disorders, CF was not diagnosed until five years after the carcinoma was resected. Incidentally, the carcinoma was located in the midtransverse colon in both patients.
In the North American and European cohort studies (1),
Figure 1) Photomicrograph of transverse colon demonstrating moderately differentiated infiltrating adenocarcinoma (solid arrow) and adjacent non-neoplastic colonic mucosa (open arrow) (hematoxylin and eosin x13.4)

Figure 2) Photomicrograph of pericolic lymph node showing extensive replacement by metastatic colonic adenocarcinoma (hematoxylin and eosin x13.4)
genotype information was available for 21 CF patients with cancers (15 Europeans and six North Americans). Fourteen patients (67%) were homozygous for the Delta-F 508 mutation. One of our patients was homozygous for Delta-F 508 and the other was shown to have Delta-F 508/unknown mutation. Delta-F 508 is the most common mutation of CF chromosomes, occurring in approximately 78% of North American Caucasians with CF (7). In British Columbia, the Delta-F 508 mutation was found in 76% of 162 CF chromosomes on DNA analysis (8) . A large number of other mutations are represented in the remaining CF chromosomes. Recently, specific genes have been identified for hereditary nonpolyposis colorectal cancer (9) . Detailed genotypic analysis can determine whether specific genotypes are responsible for colon cancer in CF patients. These patients should also be examined for all the genes known to be associated with an increased risk of colorectal cancer. A possible relationship between these known genetic abnormalities and the CF gene needs to be explored.
There is well documented evidence that the risk of gastrointestinal cancers is significantly increased in CF patients (Table 1) . For CF patients 20 to 29 years old, the odds ratio for all gastrointestinal cancers is 20.1 (1). Nine of 24 gastrointestinal cancers reported worldwide occurred in the large intestine (1) (details of these patients were not provided).
Several possible explanations for the excess risk of gastrointestinal cancers in CF patients have been proposed. The heightened risk may be related to the differential localization and expression of the CF transmembrane conductance regulator gene in various organs and the varying sensitivities of individual organs (1) . Another possible explanation is the effect of the CF disease process on the digestive system. Chronic pathological changes in organs of the digestive system, leading to increased cell turnover, may predispose CF patients to excess cancer risk in the gastrointestinal tract (1) . It is of interest, however, that despite the frequency of severe pulmonary disease in CF, bronchogenic carcinoma has never been reported in association with CF. Steatorrhea, which is common in patients with CF, has been linked to small bowel malignancy in patients with celiac disease (10). Barrett's esophagus, a known premalignant disorder, has been reported in CF patients (11) . CF patients with malabsorption have been shown to be deficient in the anti-oxidants selenium and vitamin E, which may be protective against cancer (12, 13) .
CONCLUSIONS
As the life expectancy of the CF population increases, and with well documented evidence that adult CF patients are at an increased risk of developing gastrointestinal malignancies, heightened awareness of gastrointestinal cancers is clearly important in the continued management of adult CF patients with unexplained persistent gastrointestinal symptoms. 
